These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16670114)

  • 1. Lessons learned from neutral ICD trials.
    Nisam S; Breithardt G
    Europace; 2006 Jun; 8(6):393-7. PubMed ID: 16670114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of gender on survival amongst patients with implantable cardioverter defibrillators for primary prevention against sudden cardiac death.
    Henyan NN; White CM; Gillespie EL; Smith K; Coleman CI; Kluger J
    J Intern Med; 2006 Nov; 260(5):467-73. PubMed ID: 17040253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
    Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
    Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Usefulness of the implantable cardiodefibrillator (ICD) in the prevention of sudden death. Results of evidence based medicine].
    González CM
    Arch Cardiol Mex; 2007; 77 Suppl 2():S2-44-S2-46. PubMed ID: 17972377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias.
    Healey JS; Hallstrom AP; Kuck KH; Nair G; Schron EP; Roberts RS; Morillo CA; Connolly SJ
    Eur Heart J; 2007 Jul; 28(14):1746-9. PubMed ID: 17283003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Competing risk analysis of cause-specific mortality in patients with an implantable cardioverter-defibrillator: The EVADEF cohort study.
    Marijon E; Trinquart L; Otmani A; Waintraub X; Kacet S; Clémenty J; Chatellier G; Le Heuzey JY;
    Am Heart J; 2009 Feb; 157(2):391-397.e1. PubMed ID: 19185651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indications for ICD and cardiac resynchronization therapy for prevention of sudden cardiac death.
    Das M
    Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):181-95. PubMed ID: 19210214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefits of the implantable cardioverter-defibrillator.
    Epstein AE
    J Am Coll Cardiol; 2008 Sep; 52(14):1122-7. PubMed ID: 18804737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of sudden cardiac death: rationale and design of the Implantable Cardioverter Defibrillators in Dialysis patients (ICD2) Trial--a prospective pilot study.
    de Bie MK; Lekkerkerker JC; van Dam B; Gaasbeek A; van Buren M; Putter H; van Erven L; Bax JJ; Schalij MJ; Rabelink TJ; Jukema JW
    Curr Med Res Opin; 2008 Aug; 24(8):2151-7. PubMed ID: 18561878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of statin therapy on arrhythmic events and survival in patients with nonischemic dilated cardiomyopathy.
    Goldberger JJ; Subacius H; Schaechter A; Howard A; Berger R; Shalaby A; Levine J; Kadish AH;
    J Am Coll Cardiol; 2006 Sep; 48(6):1228-33. PubMed ID: 16979011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The high cost of implantable defibrillators.
    Hlatky MA; Mark DB
    Eur Heart J; 2007 Feb; 28(4):388-91. PubMed ID: 17032689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of patients supplied with single-chamber or dual-chamber cardioverter defibrillators.
    Kolb C; Deisenhofer I; Schmieder S; Barthel P; Zrenner B; Karch MR; Schmitt C
    Pacing Clin Electrophysiol; 2006 Sep; 29(9):946-52. PubMed ID: 16981917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of early mortality in patients age 80 and older receiving implantable defibrillators.
    Ertel D; Phatak K; Makati K; Holland M; Baig S; Kim MH; Link M; Passman R
    Pacing Clin Electrophysiol; 2010 Aug; 33(8):981-7. PubMed ID: 20230459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implanted cardioverter defibrillators for the prevention of sudden death.
    Dorian P; Talajic M; Tang A
    Can J Cardiol; 2005 May; 21 Suppl A():31A-36A. PubMed ID: 15953942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of implantable cardioverter defibrillators in non-ischaemic dilated cardiomyopathy.
    Scott PA; Roberts PR
    Postgrad Med J; 2010 Feb; 86(1012):116-22. PubMed ID: 20145061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MADIT-II: substudies and their implications.
    Moss AJ;
    Card Electrophysiol Rev; 2003 Dec; 7(4):430-3. PubMed ID: 15071269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study.
    Koller MT; Schaer B; Wolbers M; Sticherling C; Bucher HC; Osswald S
    Circulation; 2008 Apr; 117(15):1918-26. PubMed ID: 18391108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of implantable cardioverter-defibrillators for prevention of sudden death in patients at high risk for ventricular arrhythmia.
    Technol Eval Cent Assess Program Exec Summ; 2005 Mar; 19(19):1-6. PubMed ID: 15793938
    [No Abstract]   [Full Text] [Related]  

  • 19. ICD therapy: what have we learned from the clinical trials?
    Arya A; Haghjoo M; Sadr-Ameli MA
    Heart Lung Circ; 2006 Feb; 15(1):3-11. PubMed ID: 16473784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA Study.
    Salerno-Uriarte JA; De Ferrari GM; Klersy C; Pedretti RF; Tritto M; Sallusti L; Libero L; Pettinati G; Molon G; Curnis A; Occhetta E; Morandi F; Ferrero P; Accardi F;
    J Am Coll Cardiol; 2007 Nov; 50(19):1896-904. PubMed ID: 17980258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.